Government Accountability

Federal Panel’s Shift on Hepatitis B Vaccine Risks America’s Health and Security

By National Security Desk | December 5, 2025

A federally appointed vaccine advisory panel, under leadership tied to anti-vaccine activism, voted to rescind the longstanding birth dose recommendation for hepatitis B vaccine, risking a resurgence of disease and undermining proven public health safeguards.

In a move that raises serious concerns about the direction of American health policy, a federal vaccine advisory committee recently voted to end the longstanding recommendation that all newborns receive the hepatitis B vaccine at birth. This decision, made by members appointed by Health Secretary Robert F. Kennedy Jr.—a figure with a controversial history in the vaccine debate—threatens to reverse decades of proven success in preventing a dangerous liver infection among vulnerable infants. Why Does Reversing This Policy Put America at Risk? Hepatitis B is more than a childhood illness; it can lead to chronic liver failure, cancer, and cirrhosis...

This is Exclusive Content for Subscribers

Join our community of patriots to read the full story and get access to all our exclusive analysis.

View Subscription Plans